Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy

Hendrik Van Poppel; Renée Hogenhout; Peter Albers; Roderick C.N. van den Bergh; Jelle O. Barentsz; Monique J. Roobol

doi:10.1016/j.eururo.2021.04.027

Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy

Hendrik Van Poppel, Renée Hogenhout, Peter Albers, Roderick C.N. van den Bergh, Jelle O. Barentsz, Monique J. Roobol

Urology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	e28-e29
Journal	European Urology
Volume	80
Issue number	1
DOIs	https://doi.org/10.1016/j.eururo.2021.04.027
Publication status	Published - 1 Jul 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2021.04.027

Cite this

Van Poppel, H., Hogenhout, R., Albers, P., van den Bergh, R. C. N., Barentsz, J. O., & Roobol, M. J. (2021). Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy. European Urology, 80(1), e28-e29. https://doi.org/10.1016/j.eururo.2021.04.027

Van Poppel, Hendrik ; Hogenhout, Renée ; Albers, Peter et al. / Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re : Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy. In: European Urology. 2021 ; Vol. 80, No. 1. pp. e28-e29.

@article{4b92fde7bea644f4a3ddd255a50645f4,

title = "Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Ren{\'e}e Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy",

author = "{Van Poppel}, Hendrik and Ren{\'e}e Hogenhout and Peter Albers and {van den Bergh}, {Roderick C.N.} and Barentsz, {Jelle O.} and Roobol, {Monique J.}",

year = "2021",

month = jul,

day = "1",

doi = "10.1016/j.eururo.2021.04.027",

language = "English",

volume = "80",

pages = "e28--e29",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "1",

}

Van Poppel, H, Hogenhout, R, Albers, P, van den Bergh, RCN, Barentsz, JO & Roobol, MJ 2021, 'Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy', European Urology, vol. 80, no. 1, pp. e28-e29. https://doi.org/10.1016/j.eururo.2021.04.027

Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy. / Van Poppel, Hendrik; Hogenhout, Renée; Albers, Peter et al.
In: European Urology, Vol. 80, No. 1, 01.07.2021, p. e28-e29.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re

T2 - Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy

AU - Van Poppel, Hendrik

AU - Hogenhout, Renée

AU - Albers, Peter

AU - van den Bergh, Roderick C.N.

AU - Barentsz, Jelle O.

AU - Roobol, Monique J.

PY - 2021/7/1

Y1 - 2021/7/1

UR - http://www.scopus.com/inward/record.url?scp=85108302913&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2021.04.027

DO - 10.1016/j.eururo.2021.04.027

M3 - Comment/Letter to the editor

C2 - 33965287

AN - SCOPUS:85108302913

SN - 0302-2838

VL - 80

SP - e28-e29

JO - European Urology

JF - European Urology

IS - 1

ER -

Van Poppel H, Hogenhout R, Albers P, van den Bergh RCN, Barentsz JO, Roobol MJ. Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy. European Urology. 2021 Jul 1;80(1):e28-e29. doi: 10.1016/j.eururo.2021.04.027

UN SDGs

Access to Document

Other files and links

Cite this